Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Future of Radionuclide Myocardial Perfusion Imaging: Transitioning from SPECT to PET

Marcelo F. Di Carli
Journal of Nuclear Medicine November 2023, 64 (Supplement 2) 3S-10S; DOI: https://doi.org/10.2967/jnumed.122.264864
Marcelo F. Di Carli
Cardiovascular Imaging Program, Departments of Radiology and Medicine; Division of Nuclear Medicine and Molecular Imaging, Department of Radiology; and Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Rest and stress SPECT and PET MPI images obtained 2 wk apart on 74-y-old man with known CAD and prior percutaneous coronary intervention presenting with recurrent chest pain. Patient initially underwent rest and stress SPECT MPI. He exercised for 10:00 min of Bruce protocol. His heart rate increased from 58 bpm at rest to peak of 134 bpm (92% of age-predicted maximal heart rate), and blood pressure increased from 130/64 mm Hg at rest to 148/62 mm Hg at peak exercise (rate–pressure product, 19,832). Patient developed chest pain and 2.5 mm of ST segment depression in leads II, III, aVF, and V3–V6, which resolved 11 min into recovery. SPECT images did not show significant perfusion defects. Patient was then referred for rest/stress PET MPI, which demonstrated large and severe perfusion defect throughout inferior and inferolateral walls with complete reversibility. This was associated with significant reduction in MFR in right coronary artery territory, associated with markedly reduced relative flow reserve. Coronary angiography showed 95% stenosis in mid right coronary artery and 70% stenosis in distal right coronary artery. There was 50% lesion in proximal left anterior descending coronary artery with normal instantaneous wave-free ratio. LAD = left anterior descending coronary artery; LCX = left circumflex coronary artery; LM = left main coronary artery; RCA = right coronary artery; RFR = relative flow reserve.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Reclassification of severe ischemia by automated perfusion assessment between PET and SPECT MPI (24). Among patients with severe ischemia by PET, 41% had either no or mild ischemia when myocardial perfusion was measured via SPECT. Conversely, among patients with severe ischemia on SPECT, 42% had less than severe ischemia by PET MPI.

  • FIGURE 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3.

    (Top) Cumulative adjusted incidence of cardiac mortality for tertiles of coronary flow reserve presented in Kaplan–Meier format showing significant association between coronary flow reserve and cardiac mortality. (Bottom) Unadjusted annualized cardiac mortality by tertiles of coronary flow reserve and categories of myocardial ischemia. Annual rate of cardiac death increased with increasing summed difference score and decreasing coronary flow reserve. Importantly, lower coronary flow reserve consistently identified higher-risk patients at every level of myocardial ischemia, including among those with visually normal PET scans and normal left ventricular function. CFR = coronary flow reserve; HR = hazard ratio. (Reprinted with permission of (36).)

  • FIGURE 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4.

    (Left) Scatterplot of coronary flow reserve and maximal MBF by cardiovascular death. Concordant and discordant impairment of coronary flow reserve and maximal MBF identifies unique prognostic phenotypes of patients. Coronary flow reserve < 2 and maximal MBF < 1.8 mL⋅g−1⋅min−1 were defined as impaired. (Right) Unadjusted annualized cardiovascular mortality for 4 groups based on concordant or discordant impairment of CFR and maximal MBF. CD = cardiac death; CFR = coronary flow reserve; CV = cardiovascular; FU = follow-up; mMBF = maximal MBF. (Reprinted with permission of (35).)

  • FIGURE 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5.

    Examples of patients with and without CMD. (A) A 58-y-old man with hypertension and diabetes evaluated for atypical chest pain. (B) A 63-y-old man with hypertension, diabetes, and high cholesterol evaluated for dyspnea. In both cases, myocardial perfusion results are normal, suggesting no evidence of flow-limiting CAD. Patient A has normal stress MBF and MFR. However, patient B shows severely reduced stress MBF and MFR. Follow-up CT coronary angiography showed no evidence of obstructive CAD. Thus, abnormalities in coronary vasoreactivity in patient B are consistent with CMD. CFR = coronary flow reserve; LAD = left anterior descending coronary artery; LCX = left circumflex coronary artery; LV = left ventricular; RCA = right coronary artery.

  • FIGURE 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 6.

    Unadjusted annualized rate of cardiac death and nonfatal myocardial infarction by coronary artery calcium score and myocardial flow reserve category. At every calcium score stratum, there is increased rate of adverse events with reduced myocardial flow reserve. MI = myocardial infarction. (Reprinted with permission of (58).)

  • FIGURE 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 7.

    Comparison of outcomes by expert reader standard CAC score from electrocardiography-gated CT vs. score calculated automatically by deep learning from PET/CT attenuation correction maps. (Top) Kaplan–Meier curves for major adverse cardiac event risk by coronary artery calcium score categories. (Bottom) Univariate major adverse cardiac event risk analysis using proportional-hazards Cox model. CAC = coronary artery calcium; CTAC = CT attenuation correction; DL = deep learning; ECG = electrocardiography. (Reprinted with permission of (70).)

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (Supplement 2)
Journal of Nuclear Medicine
Vol. 64, Issue Supplement 2
November 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Future of Radionuclide Myocardial Perfusion Imaging: Transitioning from SPECT to PET
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Future of Radionuclide Myocardial Perfusion Imaging: Transitioning from SPECT to PET
Marcelo F. Di Carli
Journal of Nuclear Medicine Nov 2023, 64 (Supplement 2) 3S-10S; DOI: 10.2967/jnumed.122.264864

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Future of Radionuclide Myocardial Perfusion Imaging: Transitioning from SPECT to PET
Marcelo F. Di Carli
Journal of Nuclear Medicine Nov 2023, 64 (Supplement 2) 3S-10S; DOI: 10.2967/jnumed.122.264864
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • TRANSFORMATIVE ROLE OF RADIONUCLIDE MPI
    • CHANGING EPIDEMIOLOGY AND CLINICAL PRESENTATION OF CAD: DOES IT MATTER?
    • INTEGRATING MBF QUANTIFICATION INTO CLINICAL PET MPI
    • EXPANDING APPLICATIONS OF QUANTITATIVE MBF WITH PET
    • INTEGRATING CT TO AUGMENT VALUE OF MPI WITH HYBRID PET/CT
    • EXPANDING ACCESS TO RADIONUCLIDE PERFUSION IMAGING WITH PET
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • SNMMI Procedure Standard/EANM Practice Guideline for Brain [18F]FDG PET Imaging, Version 2.0
  • Meeting Upcoming Clinical and Diagnostic Needs in Oncologic Imaging: A Structured Reporting System for Fibroblast-Activation-Protein–Targeted Imaging—FAP-RADS Version 1.0
  • Imaging Efficacy of [18F]CTT1057 PET for the Detection of PSMA-Positive Tumors Using Histopathology as Standard of Truth: Results from the GuideView Phase 2/3 Prospective Multicenter Study
Show more Clinical Investigation

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire